213 related articles for article (PubMed ID: 21687692)
1. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
3. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
5. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
6. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin".
Nara K; Ito S; Ito T; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
J Biochem; 1994 Mar; 115(3):441-8. PubMed ID: 7914520
[TBL] [Abstract][Full Text] [Related]
7. Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature.
Zeeuwen PL; Hendriks W; de Jong WW; Schalkwijk J
J Biol Chem; 1997 Aug; 272(33):20471-8. PubMed ID: 9252357
[TBL] [Abstract][Full Text] [Related]
8. Complete 1H, 15N and 13C assignment of trappin-2 and 1H assignment of its two domains, elafin and cementoin.
Loth K; Alami SA; Habès C; Garrido S; Aucagne V; Delmas AF; Moreau T; Zani ML; Landon C
Biomol NMR Assign; 2016 Apr; 10(1):223-6. PubMed ID: 26878852
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
11. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
12. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
[TBL] [Abstract][Full Text] [Related]
13. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y
BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308
[TBL] [Abstract][Full Text] [Related]
14. Identification, evolution, and regulation of expression of Guinea pig trappin with an unusually long transglutaminase substrate domain.
Furutani Y; Kato A; Fibriani A; Hirata T; Kawai R; Jeon JH; Fujii Y; Kim IG; Kojima S; Hirose S
J Biol Chem; 2005 May; 280(21):20204-15. PubMed ID: 15778505
[TBL] [Abstract][Full Text] [Related]
15. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
[TBL] [Abstract][Full Text] [Related]
16. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
17. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry.
Suzuki Y; Furukawa M; Abe J; Kashiwagi M; Hirose S
Histochem Cell Biol; 2000 Jul; 114(1):15-20. PubMed ID: 10959818
[TBL] [Abstract][Full Text] [Related]
18. Cementoin-SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI.
Maffía PC; Guerrieri D; Villalonga X; Caro F; Gómez S; Tateosian N; Bogado BP; Sánchez ML; Ambrosi N; Chuluyan E
Sci Rep; 2018 Mar; 8(1):5332. PubMed ID: 29593284
[TBL] [Abstract][Full Text] [Related]
19. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
20. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.
Baranger K; Zani ML; Chandenier J; Dallet-Choisy S; Moreau T
FEBS J; 2008 May; 275(9):2008-20. PubMed ID: 18341586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]